United States · FDA National Drug Code directory
Carbamazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-798_81d3a7f0-51cf-48cc-935f-770a84223619
- Product NDC
- 67877-798
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Carbamazepine
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251101
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBAMAZEPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-798-01) · 67877-798-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-798-05) · 67877-798-05
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-798-30) · 67877-798-30
- 1 BLISTER PACK in 1 CARTON (67877-798-33) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 67877-798-33
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →